Skin studies

Dr. Seth Forman never imagined he would be published in the New England Medical Journal.

“If you would have told me that when I was applying to medical school,” he says, “it would be like telling me I would fly to the moon.”

But in August, the Tampa-based dermatologist co-authored an article in the journal on treatment options for a painful chronic skin disease called hidradenitis suppurativa. His clinical research company, Forward Clinical Trials, led the country in enrollment in the study, providing 16 people for pharmaceutical firm AbbVie to use in the test run.